Electrophysiology Devices Market 2018-2026| Size, Share, Opportunities and Forecast | Credence Research

Apr 3, 2019

The electrophysiology devices market was valued at US$ 6,513.3 Mn in 2017 and projected to reach US$ 16,730.2 Mn by 2026 at a CAGR of 10.9% over the forecast period from 2018 to 2026.

SANJOSE, United States - April 3, 2019 /MarketersMedia/ —

The latest market report published by Credence Research, Inc. "Electrophysiology Devices Market Growth, Future Prospects, and Competitive Analysis, 2018–2026" the market for electrophysiology devices was valued at US$ 6,513.3 million in 2017 and projected to reach US$ 16,730.2 million by 2026 at a CAGR of 10.9 percent over the forecast period from 2018 to 2026.

The market for electrophysiology (EP) devices is likely to witness a phenomenal CAGR during the 2018-2026 forecast period. Electrophysiology, the branch of physiology, is a test performed to assess the heart's electrical system/activity and to diagnose abnormal heartbeats or arrhythmia. A growing aging population coupled with increasing prevalence of atrial fibrillation (AF) & cardiovascular diseases (CVDs), technological advancements in electrophysiology devices, and the presence of favorable government initiatives are factors driving market growth.

Browse the full report Electrophysiology Devices Market Growth, Future Prospects, and Competitive Analysis, 2018–2026 at https://www.credenceresearch.com/report/electrophysiology-devices-market

Technological developments in electrophysiology devices such as fluoroscopy integrated 3D mapping technology in ablation, a bidirectional duodecapolar diagnostic catheter, irrigated RF catheters and remote steering systems fuel the demand for EP devices. Additionally, novel techniques including convergent procedure, WATCHMAN left atrial appendage closure (LAAC) procedure, and focal impulse and rotor modulation (FIRM) are gaining momentum among patients and healthcare professionals (HCPs). On the contrary, high electrophysiology device costs and the availability of alternative therapies are expected to hinder market growth during the forecast period.

The introduction of the Million Hearts CVD Risk Reduction model that will bridge a gap in cardiovascular care by giving targeted incentives to health care providers (HCPs) or practitioners to engage in beneficiary cardiovascular disease (CVD) risk calculation and population-level risk management is supposed to support market growth. Globally, electrophysiology devices market to witness a profitable growth with a CAGR of 10.9 percent over the forecast period from 2018 to 2026. 

The electrophysiology ablation catheters segment would follow the electrophysiology laboratory devices in terms of revenue based on the product. Due to the advent of implantable cardiac monitors to monitor atrial fibrillation, the cardiac monitor segment will exhibit the fastest CAGR during the forecast period. Increasing the prevalence of atrial fibrillation (Afib) worldwide coupled with increasing adoption of electrophysiology devices and procedures would support the supremacy of the atrial fibrillation indication throughout the 2017 forecast period and maintain its status quo throughout the forecast period due to the presence of key market participants & target.

The rising prevalence of atrial fibrillation (Afib) across the world coupled with increasing adoption of electrophysiology devices and procedures would support the supremacy of the atrial fibrillation indication throughout the forecast period

North America commanded the market in 2017 and would retain its status quo throughout the forecast period due to the presence of key market participants & target population, and favorable reimbursement & coverage scenario for electrophysiology procedures in the U.S. and Canada

Asia Pacific is foreseen to demonstrate comparatively higher CAGR during the forecast period between 2018 & 2026 due to surging elderly population base coupled with increasing prevalence of atrial fibrillation, Wolff-Parkinson-White (WPW) syndrome, and cardiovascular diseases in India, China, Japan, and Australia

Major players in this vertical are Siemens Healthineers; Medtronic plc; Boston Scientific Corporation; Abbott Laboratories; Biosense Webster, Inc. (Johnson & Johnson Services, Inc.); BIOTRONIK SE & Co. KG; Nihon Kohden Corporation; MicroPort Scientific Corporation; CardioFocus, Inc.; and Stereotaxis, Inc.

Get Sample (Free) @ https://www.credenceresearch.com/sample-request/59377

ToC:
Chapter 1 Preface
1.1 Report Scope and Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Approaches Adopted
1.3.4.1 Top-Down Approach
1.3.4.2 Bottom-Up Approach
1.3.5 Assumptions
1.4 Market Segmentation

Chapter 2 Executive Summary
............
Chapter 3 Market Dynamics
............
Chapter 4 Global Electrophysiology Devices Market, by Product, 2016–2026 (US$ Mn)
4.1 Overview
4.2 Electrophysiology Laboratory Devices
4.2.1 Electrophysiology X-Ray Systems
4.2.2 Electrophysiology Imaging, Mapping & Recording Systems
4.2.3 Intracardiac Echocardiography (ICE) Systems
4.2.4 Radiofrequency (RF) Ablation Generators
4.2.5 Electrophysiology Remote Steering Systems
4.3 Electrophysiology Ablation Catheters
4.4 Electrophysiology Diagnostic Catheters
4.4.1 Fixed Diagnostic Catheters
4.4.2 Steerable Diagnostic Catheters
4.5 Cardiac Monitors
4.6 Cardiac Resynchronization Therapy Devices (CRTs)
4.7 Implantable Cardioverter Defibrillators (ICDs)
4.8 Access Devices
4.9 Left Atrial Appendage (LAA) & Closure Devices

Chapter 5 Global Electrophysiology Devices Market, by Indication, 2016–2026 (US$ Mn)
5.1 Overview
5.2 Atrial Fibrillation (AF)
5.3 Atrial Flutter (AFL)
5.4 Wolff-Parkinson-White (WPW) Syndrome
5.5 Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
5.6 Others (retinal diseases and optic nerve diseases)

Chapter 6 Global Electrophysiology Devices Market, by Geography, 2016–2026 (US$ Mn)
..............
Chapter 7 Company Profiles
7.1 Siemens Healthineers
7.2 Medtronic plc
7.3 Boston Scientific Corporation
7.4 Abbott Laboratories
7.5 Biosense Webster, Inc. (Johnson & Johnson Services, Inc.)
7.6 BIOTRONIK SE & Co. KG
7.7 Nihon Kohden Corporation
7.8 MicroPort Scientific Corporation
7.9 CardioFocus, Inc.
7.10 Stereotaxis, Inc.
.............................toc continued

Browse the full report Electrophysiology Devices Market Growth, Future Prospects, and Competitive Analysis, 2018–2026 at https://www.credenceresearch.com/report/electrophysiology-devices-market

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com

Source URL: https://marketersmedia.com/electrophysiology-devices-market-2018-2026-size-share-opportunities-and-forecast-credence-research/498379

Source: MarketersMedia

Release ID: 498379

More News

Quezon tops South qualifier; Imus clinches last play-in slot in MPBL
Sep 22, 2026

Quezon tops South qualifier; Imus clinches last play-in slot in MPBL

MANILA, Philippines — The Quezon Huskers subdued the Rizal XentroMall Golden Coolers, 90-74, to top the elimination phase of the SportsPlus MPBL (Maharlika Pilipinas Basketball League) 2026 Season South Division at the Bulacan Capitol Gymnasium in Malolos. Quezon improved its record to  21-4, the same as Binan Tatak Gel, but emerged as the No. 1 qualifier to the quarterfinal playoffs because of its 66-59 victory in their April 21 encounter. Although the Huskers led throughout, the reigning back-to-back South champions experienced anxious moments as the Golden Coolers crept to within 55-58 after three quarters. Cholo Anonuevo, however, hit his stride in the fourth quarter with 8 points and Christian Pagaran added 6, pushing the Huskers out of danger and pulling down the Golden Coolers to 16-9. MPBL All-Star co-MVP Judel Fuentes led Quezon with 14 points, 4 assists, 3 rebounds and 2 steals; followed by Jason Opiso, with 14 points and 6 rebounds; Anonuevo, with 13 points, 6 rebounds and 4 assists; and Pagaran, with 11 points and 8 rebounds. Rizal, which remained the No. 6 qualifier, drew 20 points and 8 rebounds from JP Maguliano; 12 points and 5 assists from Philip Manalang; and 10 points and 5 assists from Jolo Mendoza. Gensan trounces Bulacan The Gensan Warriors started hot and never cooled to beat the Bulacan Kuyas, 102-82, in the nightcap and catch up with the Cebu Greats and the Batangas City Tanduay Athletics at 19-6. After the tiebreaker, Cebu finished third, and Batangas City fourth, owing to its 76-73 victory over Gensan on Sept. 18. RJ Minerva paced Gensan with 17 points, 9 rebounds and 3 assists, followed by Hesed Gabo, with 14 points, 7 assists, 3 steals and 2 rebounds; and Kris Porter with 10 points. Joshua Fontanilla, Samboy De Leon and JM Versoza supported them with 9 points each. Bulacan, which ended its campaign at 6-19, got 17 points, 10 rebounds, 5 assists and 2 steals from Andre Acop; 15 points, 6 rebounds, 3 assists and 2 steals from Jeremy Cruz; and 11 points and 2 assists from Benedict Benedictos. Imus grabs last play-in ticket The Imus Yangkee bested the Sarangani 10ACT Marlins, 89-84, in the opener to grab the last ticket to the play-in stage. Imus finished at 4-21, good for the 10th spot in the South Division, and will tangle with ninth-ranked Zamboanga Sikat in the play-in involving teams ranked seventh to 10th after the round-robin elimination phase of the two-division, 26-team tournament. The winner between Imus and Zamboanga will then dispute the eighth and last playoff slot with the loser of the other play-in game between seventh-ranked Mindoro and No. 8 Basilan. The winner of the Mindoro-Zamboanga tussle advances outright to the quarterfinal playoffs. Sarangani closed its campaign this year with a 3-22 record. Joseph Marquez, a 6-foot-3 forward out of Our Lady of Fatima University, posted 17 points, 8 rebounds, 3 assists and 3 steals for Imus and was named the SportsPlus best player. Other Yangkees who delivered were Ian Pardo, with 16 points, including three game-clinching free throws in the last 8.7 seconds; homegrown Paul Christian Ferrer, with 13 points and 8 rebounds; and homegrown Patrick Dale Beltran, with 12 points, 7 rebounds and 3 assists. Sarangani drew 21 points, 13 rebounds and 5 assists from Carl Bryan Lacap; 13 points, 5 rebounds and 2 assists from John Cantimbuhan; 10 points, 7 assists, 4 rebounds and 2 steals from Alex Desoyo; and 8 points, 15 rebounds and 3 assists from Ken Brillantes. The tournament returns to the Pasay Astrodome on Tuesday, featuring games between Caloocan and Zamboanga at 3 p.m., Pasay City and Pasig City at 5 p.m., and Valenzuela City and Quezon City at 7 p.m. TMT

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.